The aim of this project is to develop ionically-complexed, and covalently-linked anti-inflammatory and bronchodilator combinations for the treatment of respiratory disorders such as asthma or COPD. Using an in-vitro superfusion assay bronchodilation activity will be assessed. The effectiveness of lead compounds will be examined in in-vivo bronchoconstriction and inflammatory models. The complexes will also be developed as a suitable delivery system and characterised for the suitability for administration in clinical setting.
|Effective start/end date||2/01/18 → 31/12/19|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.